Ozempic, Wegovy, Mounjaro, and Zepbound for Weight Loss


Ozempic and Wegovy are injectable weight loss medications. Containing the active ingredient 'semaglutide', these GLP-1 drugs help control the blood sugar level of diabetics and people susceptible to heart illnesses. They also help in lowering the risk of major cardiovascular issues like strokes and heart attacks.

Mounjaro (known chemically as 'tirzepatide') is an all-natural weight loss supplement designed to help you lose weight quickly and effectively. It has been clinically proven that Mounjaro for weight loss is helpful for people with Type 2 diabetes, as it contains a powerful blend of antioxidants, which protects your body from free radical damage.

Tirzepatide is also an active ingredient in Zepbound, a fixed-dose weight loss medication. It should be used along with physical exercise and a balanced diet.

Obesity and its Effects on Health



Obesity is a chronic condition, caused by excessive calorie consumption, wherein your body accumulates a disproportionate amount of fat. Generally, a Body Mass Index (BMI) of 30 or higher is associated with obesity, while people with a BMI of 25 or higher are classified as overweight. 

Having extra body fat adversely affects the way your body functions. For instance, obesity can cause certain chemical changes in your blood, leading to increased risk for heart disease, stroke, and diabetes. Another common factor in obesity is metabolic syndrome, contributing to type 2 diabetes, gallstones, fatty liver disease, and cardiovascular diseases. Hormones and other chemicals secreted by enlarged fat cells can also produce chronic inflammation, which can then lead to high blood sugar and blood pressure.

Every weight loss method might not work for every person suffering from obesity. A combination of exercise and a balanced diet may be enough for some; for others, medications like Zepbound, Mounjaro, Wegovy, and Ozempic for weight loss may be more effective.


How Do Ozempic, Wegovy, Mounjaro, and Zepbound Work?


Ozempic works by increasing feelings of fullness and reducing hunger by delaying gastric emptying. It mimics the effect of GLP-1 hormones. GLP-1, or Glucagon-like Peptide-1, refers to the hormone that helps in regulating metabolism and appetite. It makes you feel full, so you consume a lesser amount of calories. This medication helps better control diabetes and lose weight.

Having a higher dose of semaglutide than Ozempic, Wegovy comes in a single-dose pen. Like Ozempic, it mimics GLP-1 and works in a similar manner.

Both Mounjaro and Zepbound activate the GIP or glucose-dependent insulinotropic polypeptide receptors, as well as the GLP-1 or Glucagon-like peptide-1 receptors. They decrease food intake by slowing down the speed with which food travels through the digestive tract. This makes you feel fuller for a long period of time; as a result, reducing the quantity of food you eat. Mounjaro affects insulin metabolism as well, by enhancing insulin secretion when blood sugar levels are high. It also reduces glucose production from the liver. This, in turn, helps reduce weight.


Our Approach





  • Ozempic is provided based on strict doctor supervision, as it might not suit everyone, due to its side effects.
  • Ozempic for weight loss is used in conjunction with exercise and diet for best results.
  • It is usually given as an injection once a week and can help in losing body weight by 5-15%.
  • Dose adjustments are usually made every 4 weeks based on the patient’s tolerance level to control the amount of weight loss.
  • Nutritional support and metabolic optimization are paramount to get the best response.




  • Wegovy for weight loss is injected under the skin once a week.
  • The recommended inital Wegovy dosage once per week is 0.25mg, and is gradually increased based on the doctor's suggestions.
  • Each Wegovy pen is safely disposed of after use.
  • It shouldn't be used along with Ozempic or other drugs containing semaglutide.




  • Along with exercise and a balanced diet, Mounjaro is used for lowering the blood glucose levels of patients suffering from type 2 diabetes mellitus.
  • It is provided under strict medical supervision and needs close monitoring.
  • Mounjaro is injected under the skin in the abdomen area, on the upper arm, or thigh skin, once a week.




  • A Zepbound weight loss injection should be administered at least 3 days (72 hours) apart.
  • It's injected once a week under the skin of your abdomen, upper arm, or thigh.
  • Each weekly injection should be given at a different injection site.
  • The starting dose is 2.5mg, which can be increased after 4 weeks to see if it works for you.
  • You can't use Zepbound if you have Multiple Endocrine Neuoplasia Syndrome type 2 (MEN 2) or medullary thyroid carcinoma (MTC). 

Request an Appointment